Pages that link to "Q81582287"

The following pages link to Synthesis and evaluation of a potent and selective cell-permeable p300 histone acetyltransferase inhibitor (Q81582287):

Displaying 28 items.

• A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange (Q24648525) (← links)
• The multifaceted role of lysine acetylation in cancer: prognostic biomarker and therapeutic target (Q26744292) (← links)
• KATs in cancer: functions and therapies (Q26859355) (← links)
• Protein lysine acetylation by p300/CBP (Q27021749) (← links)
• The structural basis of protein acetylation by the p300/CBP transcriptional coactivator (Q27649849) (← links)
• Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor (Q33599508) (← links)
• Chromatin remodeling pathways in smooth muscle cell differentiation, and evidence for an integral role for p300. (Q33778262) (← links)
• Therapeutic strategies to inhibit MYC (Q34355349) (← links)
• BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy (Q34360164) (← links)
• Chemoproteomic profiling of lysine acetyltransferases highlights an expanded landscape of catalytic acetylation (Q34489555) (← links)
• Spermidinyl-CoA-based HAT inhibitors block DNA repair and provide cancer-specific chemo- and radiosensitization (Q34887304) (← links)
• The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation (Q35650662) (← links)
• Microfluidic Mobility Shift Profiling of Lysine Acetyltransferases Enables Screening and Mechanistic Analysis of Cellular Acetylation Inhibitors. (Q35795817) (← links)
• Live-cell studies of p300/CBP histone acetyltransferase activity and inhibition (Q36452936) (← links)
• Histone acetyltransferase inhibitor anacardic acid causes changes in global gene expression during in vitro Plasmodium falciparum development (Q36746991) (← links)
• Chemical probes for histone-modifying enzymes (Q37272504) (← links)
• Metabolic mechanisms of epigenetic regulation (Q37570097) (← links)
• AML1-ETO driven acute leukemia: insights into pathogenesis and potential therapeutic approaches (Q38033116) (← links)
• Ghrelin O-acyltransferase assays and inhibition (Q38043203) (← links)
• Epigenetic chemical probes. (Q38055063) (← links)
• MYC in pancreatic cancer: novel mechanistic insights and their translation into therapeutic strategies (Q38539670) (← links)
• Structure-Activity Relationships on Cinnamoyl Derivatives as Inhibitors of p300 Histone Acetyltransferase. (Q40271872) (← links)
• Probing the reaction coordinate of the p300/CBP histone acetyltransferase with bisubstrate analogs (Q42716436) (← links)
• Substituting N(epsilon)-thioacetyl-lysine for N(epsilon)-acetyl-lysine in peptide substrates as a general approach to inhibiting human NAD(+)-dependent protein deacetylases (Q43187910) (← links)
• Synthesis of benzamides related to anacardic acid and their histone acetyltransferase (HAT) inhibitory activities (Q46553505) (← links)
• Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors (Q47153340) (← links)
• Global Profiling of Acetyltransferase Feedback Regulation. (Q53108818) (← links)
• Inhibitor of CBP Histone Acetyltransferase Downregulates p53 Activation and Facilitates Methylation at Lysine 27 on Histone H3 (Q58692929) (← links)